Remove Containment Remove Drug Delivery Remove Licensing
article thumbnail

FOSTAIR inhaler – TOP questions & ANSWERS

Druggist

Formoterol, which belongs to a group of drugs called long-acting beta2-agonist ( LABA ). As we already learned from the above combination inhaler in asthma contains two ingredients, one of which is inhaled corticosteroid and the other LABA. Initial license for Fostair included only maintenance therapy in adults over 18 years of age.

article thumbnail

BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC

The Pharma Data

With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

TLC Announces the Appointment of Thomas H. Bliss, Jr., MBA, as Chief Business Officer

The Pharma Data

We look forward to successful commercialization and licensing of TLC’s programs across the globe under Mr. Bliss’s leadership, as well as to creating benefit and bringing value for all of TLC’s stakeholders.”. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

article thumbnail

BetterLife Pharma Strengthens Board of Directors

The Pharma Data

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. About BetterLife Pharma Inc. BetterLife Pharma Inc.

article thumbnail

BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada

The Pharma Data

Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV).

article thumbnail

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

The Pharma Data

Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.

article thumbnail

Injecting Innovation: The Rising Trend of Autoinjectors in Modern Medicine

Roots Analysis

In July 2023, Crossject partnered with AFT Pharmaceuticals for licensing, distribution and promotion of ZENEO Midazolam for patients with epileptic seizures in Australia and New Zealand. Reduced Medication Errors: As the autoinjectors contain the exact dose of medication, they enable reduced dosing errors.